Polimorfizmi gena MTHFR i njihove biohemijske asocijacije sa vitaminom D u serumu i IL-17 u ulceroznom kolitisu

MTHFR Variants and Biochemical Markers in Ulcerative Colitis

  • Guang Chen Prva povezana bolnica Heilongjiang Univerzitet kineske medicine
  • Meihong Yan Bolnica za rak Medicinskog univerziteta u Harbinu
  • Xiaoyang Hu Osnovni Medicinski fakultet Heilongjiang Univerziteta kineske medicine
  • Hanfei Xu Prva povezana bolnica Heilongjiang Univerzitet kineske medicine
  • Shengai Piao Second Affiliated Hospital Heilongjiang University of Chinese Medicine
DOI: https://doi.org/10.5937/jomb0-62831

Sažetak


Background: Disturbances in homocysteine metabolism and immune-inflammatory pathways may contribute to the pathogenesis of ulcerative colitis (UC). Methylenetetrahydrofolate reductase (MTHFR) plays a central biochemical role in homocysteine remethylation, and its genetic variants may influence downstream biomarkers such as vitamin D and interleukin-17 (IL-17). This study examined the associations of three MTHFR polymorphisms (rs110298, rs132981, rs167281) with UC susceptibility, disease characteristics, and related biochemical markers.

Patients and methods: A total of 124 UC patients and 128 healthy controls were enrolled. Genotyping of MTHFR SNPs was performed by PCR amplification followed by ligase detection reaction. Serum 25-hydroxyvitamin D was measured using electrochemiluminescence immunoassay, and IL-17 levels were quantified by ELISA. Associations between MTHFR genotypes, UC onset, disease location, severity, and biochemical markers were statistically evaluated.

Results: All polymorphisms conformed to Hardy–Weinberg equilibrium. The rs110298 GG genotype and rs132981 TT genotype were significantly more frequent in UC patients than controls (P < 0.05), whereas rs167281 showed no association with UC. Both rs110298 and rs132981 were linked to UC disease location and severity (P < 0.05). UC patients exhibited significantly reduced serum vitamin D and elevated IL-17 levels compared with controls (P < 0.05). Importantly, rs110298 (AG/GG) and rs132981 (TT) genotypes were associated with lower vitamin D and higher IL-17 concentrations in UC patients (P < 0.05), indicating a biochemical effect of MTHFR variants on inflammatory and immunomodulatory pathways.

Conclusions: MTHFR polymorphisms rs110298 and rs132981 are significantly associated with UC susceptibility and clinical phenotype and exert measurable biochemical effects on serum vitamin D and IL-17 levels. These findings highlight the potential value of MTHFR-related pathways as biomarkers for disease characterization and as mechanistic contributors to UC-related immune dysregulation.

Reference

1. Garg M, Hendy P, Ding JN, Shaw S, Hold G, Hart A. The Effect of Vitamin D on Intestinal Inflammation and Faecal Microbiota in Patients with Ulcerative Colitis. J Crohns Colitis 2018; 12(8): 963-72.
2. Dubinsky MC, Cross RK, Sandborn WJ, Long M, Song X, Shi N, et al. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2018; 24(9): 1876-82.
3. Suskind DL, Cohen SA, Brittnacher MJ, Wahbeh G, Lee D, Shaffer ML, et al. Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease. J Clin Gastroenterol 2018; 52(2): 155-63.
4. Chaparro M, Verreth A, Lobaton T, Gravito-Soares E, Julsgaard M, Savarino E, et al. Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. Am J Gastroenterol 2018; 113(3): 396-403.
5. Refsum H, Helland S, Ueland PM. Radioenzymic determination of homocysteine in plasma and urine. Clin Chem 1985; 31(4): 624-8.
6. Castro R, Rivera I, Struys EA, Jansen EEW, Ravasco P, Camilo ME, et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 2003; 49(8): 1292-6.
7. Fokkema MR, Gilissen MF, Van Doormaal JJ, Volmer M, Kema IP, Muskiet FAJ. Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia. Clin Chem 2003; 49(5): 818-21.
8. Danese S, Sgambato A, Papa A, Scaldaferri F, Pola R, Sans M, et al. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol 2005; 100(4): 886-95.
9. Hollis BW, Napoli JL. Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status. Clin Chem 1985; 31(11): 1815-9.
10. Bruce D, Yu S, Ooi JH, Cantorna MT. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol 2011; 23(8): 519-28.
11. Han J, Colditz GA, Hunter DJ. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 2007; 28(2): 390-7.
12. Zhou Y, Xu ZZ, He Y, Yang Y, Liu L, Lin Q, et al. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction. Msystems 2018; 3(1):
13. Stenson WF. Interleukin-4 hyporesponsiveness in inflammatory bowel disease: immune defect or physiological response? Gastroenterology 1995; 108(1): 284-6.
14. Neuman MG. Immune dysfunction in inflammatory bowel disease. Transl Res 2007; 149(4): 173-86.
15. Peyrin-Biroulet L, Rodriguez-Gueant R, Chamaillard M, Desreumaux P, Xia B, Bronowicki J, et al. Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Am J Gastroenterol 2007; 102(5): 1108-15.
16. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Bmj-Brit Med J 2002; 325(7374): 1202.
17. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001; 47(5): 887-92.
18. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001; 22(4): 195-201.
19. Motti C, Gnasso A, Bernardini S, Massoud R, Pastore A, Rampa P, et al. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease. Atherosclerosis 1998; 139(2): 377-83.
20. Schroecksnadel K, Frick B, Winkler C, Wirleitner B, Weiss G, Fuchs D. Atorvastatin suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells. Clin Chem Lab Med 2005; 43(12): 1373-6.
21. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010; 10(4): 482-96.
22. Xia Y, Chen H, Xiao H, Yang J, Li Z, Wang Y, et al. Immune regulation mechanism of vitamin D level and IL-17/IL-17R pathway in Crohn's disease. Exp Ther Med 2019; 17(5): 3423-8.
Objavljeno
2026/01/15
Broj časopisa
Ahead of print
Rubrika
Original paper

Sva prava zadržana (c) 2026 Guang Chen, Meihong Yan, Xiaoyang Hu, Hanfei Xu, Shengai Piao

Creative Commons License

Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.